Loenen, Netherlands

Ilse Roodink

USPTO Granted Patents = 4 



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Ilse Roodink: A Pioneer in Antibody Research

Introduction

Ilse Roodink is a notable inventor based in Loenen, Netherlands, recognized for her groundbreaking contributions to the field of biotechnology and medical research. With four patents to her name, her work primarily focuses on the development of neutralizing antibodies that target betacoronaviruses, including the SARS-CoV-2 virus responsible for COVID-19.

Latest Patents

Roodink's latest patents revolve around anti-spike glycoprotein antibodies and their therapeutic applications. These patents detail the creation of neutralizing antibodies or antigen-binding fragments designed to combat betacoronavirus infections. The key features of her patents include the ability of these antibodies to block viral entry into host cells and to trigger immune responses such as complement-dependent cytotoxicity (CDC) and antibody-dependent cellular phagocytosis (ADCP). Additionally, her research encompasses methods for employing these antibodies in therapeutic, diagnostic, and preventative strategies against COVID-19 and related diseases.

Career Highlights

Throughout her career, Ilse Roodink has worked with esteemed organizations in the biotechnology sector. Notably, she has contributed her expertise at Modiquest B.V. and Talem Therapeutics LLC, where her innovative approach to antibody therapy has propelled advancements in the fight against viral infections. Roodink's relentless pursuit of solutions in therapeutic research marks her as a significant figure in her field.

Collaborations

Ilse has collaborated with distinguished professionals, including Wilhelmus Petrus Johannes Leenders and Jozef Maria Hendrik Raats. These partnerships have facilitated the exchange of knowledge and ideas, leading to innovative breakthroughs in antibody research and the therapeutic applications of her patents.

Conclusion

Ilse Roodink's contributions to antibody research have solidified her reputation as an influential inventor in the field of biotechnology. Her innovative patents offer promising avenues for combating betacoronavirus infections, showcasing the vital role of inventors in advancing medical science. As she continues her work, the impact of her inventions is poised to be profoundly felt in the realm of healthcare and disease prevention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…